CONMED Corp
corporate_fare Company Profile
CONMED Corp (NYSE:CNMD) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 19 items for CNMD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-28, rated 7/10. Across its 19 most recent items scored 7 or higher, the top rating is 9/10, with 10 rated 8 or above. Recent SEC coverage for CNMD spans 10-Q, 8-K, DEF 14A, 10-K.
Recent high-impact activity:
- CONMED Q3 Sales Slip 0.7% but Organic Growth Hits 6.7%; EPS Guidance Raised
- CONMED Q2 GAAP EPS Up 11.6%, Details Convertible Note Repurchase & Strategic Divestiture
- CONMED Beats Q2 Views, Raises EPS Guidance on Strong Organic Growth
- FDA Clears CONMED's AirSeal for da Vinci 5 Hex Cannula, Expanding Robotic Surgery Reach
- Conmed Weighs Sale After Receiving Takeover Interest
Financial Snapshot
Short Interest & Short Volume
4.29 days to coverFINRA reported short interest of 1,861,112 shares in CNMD as of the October 30, 2026 settlement, a 2.7% decrease from the prior period — about 4.3 days to cover at its recent average daily volume. On November 20, 2026, 70.0% of CNMD volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.